These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 15467019

  • 1. Utility of currently available modes of therapy in reaching lipid goals.
    Spratt KA, Denke MA.
    J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S14-6. PubMed ID: 15467019
    [Abstract] [Full Text] [Related]

  • 2. Coadministration of multidrug therapy to achieve lipid goals.
    Denke MA.
    J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S17-22. PubMed ID: 15467020
    [Abstract] [Full Text] [Related]

  • 3. Reducing the risk of coronary heart disease via lipid reduction.
    Spratt KA.
    J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S9-13. PubMed ID: 15467018
    [Abstract] [Full Text] [Related]

  • 4. Drugs for lipids.
    Treat Guidel Med Lett; 2005 Mar; 3(31):15-22. PubMed ID: 15726011
    [No Abstract] [Full Text] [Related]

  • 5. Management of hypertriglyceridemia.
    Oh RC, Lanier JB.
    Am Fam Physician; 2007 May 01; 75(9):1365-71. PubMed ID: 17508532
    [Abstract] [Full Text] [Related]

  • 6. Lipid management in the geriatric patient.
    Nair AP, Darrow B.
    Endocrinol Metab Clin North Am; 2009 Mar 01; 38(1):185-206. PubMed ID: 19217519
    [Abstract] [Full Text] [Related]

  • 7. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.
    J Cardiovasc Pharmacol; 2008 Apr 01; 51(4):331-51. PubMed ID: 18427276
    [Abstract] [Full Text] [Related]

  • 8. Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.
    Visnegarwala F, Maldonado M, Sajja P, Minihan JL, Rodriguez-Barradas MC, Ong O, Lahart CJ, Hasan MQ, Balasubramanyam A, White AC.
    J Infect; 2004 Nov 01; 49(4):283-90. PubMed ID: 15474625
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R, Goldberg AC.
    Endocrinol Metab Clin North Am; 2009 Mar 01; 38(1):79-97. PubMed ID: 19217513
    [Abstract] [Full Text] [Related]

  • 11. Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents.
    Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH.
    Am J Cardiol; 2006 Nov 01; 98(9):1231-3. PubMed ID: 17056335
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R, Mahajan M, Singh B, Bal BS, Kant R.
    J Indian Med Assoc; 2006 Sep 01; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [Abstract] [Full Text] [Related]

  • 13. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
    Broncel M, Balcerak M, Chojnowska-Jezierska J.
    Pol Merkur Lekarski; 2007 Jan 01; 22(127):62-5. PubMed ID: 17477094
    [Abstract] [Full Text] [Related]

  • 14. Choosing drug therapy for patients with hyperlipidemia.
    Safeer RS, Lacivita CL.
    Am Fam Physician; 2000 Jun 01; 61(11):3371-82. PubMed ID: 10865931
    [Abstract] [Full Text] [Related]

  • 15. Effect of lipid-lowering drug therapy on small-dense low-density lipoprotein.
    Backes JM, Gibson CA.
    Ann Pharmacother; 2005 Mar 01; 39(3):523-6. PubMed ID: 15671087
    [Abstract] [Full Text] [Related]

  • 16. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ, Yellon DM.
    Heart; 2008 Jun 01; 94(6):706-14. PubMed ID: 18480348
    [Abstract] [Full Text] [Related]

  • 17. Optimal management of cholesterol levels and the prevention of coronary heart disease in women.
    Mosca LJ.
    Am Fam Physician; 2002 Jan 15; 65(2):217-26. PubMed ID: 11820486
    [Abstract] [Full Text] [Related]

  • 18. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.
    Svilaas A, Strandberg T, Eriksson M, Hildebrandt P, Westheim A.
    Scand Cardiovasc J; 2008 Aug 15; 42(4):279-87. PubMed ID: 18609053
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy for dyslipidemia.
    Spellman CW.
    J Am Osteopath Assoc; 2003 Jan 15; 103(1 Suppl 1):S9-11. PubMed ID: 12572624
    [Abstract] [Full Text] [Related]

  • 20. Treatment of high-risk older persons with lipid-lowering drug therapy.
    Aronow WS.
    Am J Ther; 2008 Jan 15; 15(2):102-7. PubMed ID: 18356628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.